You actually raise an important point—murcidencel is not only in one country. RAs around the world are involved and will have the opportunity to approve the murcidencel cell-based technology in their respective nations or union of nations. Northwest Biotherapeutics is preparing RA filings and manufacturing capacity to address a global market.
Watch for the forthcoming NICE developments. They will further validate the P3 data and the significance of this landmark study. These developments have recently begun to update in recent posting on the NICE website and significant developments could further unfold in advance of the FDA.
Market Data 
Markets 
AI
